BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33746963)

  • 1. Complement and
    Kohn M; Lanfermann C; Laudeley R; Glage S; Rheinheimer C; Klos A
    Front Immunol; 2021; 12():626627. PubMed ID: 33746963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci.
    Bode J; Dutow P; Sommer K; Janik K; Glage S; Tümmler B; Munder A; Laudeley R; Sachse KW; Klos A
    PLoS One; 2012; 7(11):e50327. PubMed ID: 23189195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement and
    Kohn M; Lanfermann C; Laudeley R; Glage S; Rheinheimer C; Klos A
    Front Immunol; 2021; 12():580594. PubMed ID: 33767691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complement C3a receptor is critical in defense against Chlamydia psittaci in mouse lung infection and required for antibody and optimal T cell response.
    Dutow P; Fehlhaber B; Bode J; Laudeley R; Rheinheimer C; Glage S; Wetsel RA; Pabst O; Klos A
    J Infect Dis; 2014 Apr; 209(8):1269-78. PubMed ID: 24273177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct intensity of host-pathogen interactions in Chlamydia psittaci- and Chlamydia abortus-infected chicken embryos.
    Braukmann M; Sachse K; Jacobsen ID; Westermann M; Menge C; Saluz HP; Berndt A
    Infect Immun; 2012 Sep; 80(9):2976-88. PubMed ID: 22689815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice: IL-12 is dominant over IL-18 for protective immunity.
    Lu H; Yang X; Takeda K; Zhang D; Fan Y; Luo M; Shen C; Wang S; Akira S; Brunham RC
    Mol Med; 2000 Jul; 6(7):604-12. PubMed ID: 10997341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia.
    Mueller-Ortiz SL; Drouin SM; Wetsel RA
    Infect Immun; 2004 May; 72(5):2899-906. PubMed ID: 15102802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue.
    Huang J; Wang MD; Lenz S; Gao D; Kaltenboeck B
    J Immunol; 1999 Feb; 162(4):2217-26. PubMed ID: 9973497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
    Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
    Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection.
    Yang X; Brunham RC
    J Immunol; 1998 Aug; 161(3):1439-46. PubMed ID: 9686609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host-pathogen interactions in specific pathogen-free chickens following aerogenous infection with Chlamydia psittaci and Chlamydia abortus.
    Kalmar I; Berndt A; Yin L; Chiers K; Sachse K; Vanrompay D
    Vet Immunol Immunopathol; 2015 Mar; 164(1-2):30-9. PubMed ID: 25638671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.
    Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of Chlamydia muridarum within dendritic cells.
    Rey-Ladino J; Jiang X; Gabel BR; Shen C; Brunham RC
    Infect Immun; 2007 Aug; 75(8):3707-14. PubMed ID: 17502393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia-host cell interaction not only from a bird's eye view: some lessons from Chlamydia psittaci.
    Radomski N; Einenkel R; Müller A; Knittler MR
    FEBS Lett; 2016 Nov; 590(21):3920-3940. PubMed ID: 27397851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function.
    Bai H; Cheng J; Gao X; Joyee AG; Fan Y; Wang S; Jiao L; Yao Z; Yang X
    J Immunol; 2009 Nov; 183(9):5886-95. PubMed ID: 19812198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement C3 opsonization of Chlamydia trachomatis facilitates uptake in human monocytes.
    Lausen M; Christiansen G; Karred N; Winther R; Poulsen TBG; Palarasah Y; Birkelund S
    Microbes Infect; 2018; 20(6):328-336. PubMed ID: 29729435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immunity induced by recombinant protein CPSIT_p8 of Chlamydia psittaci.
    Liang M; Wen Y; Ran O; Chen L; Wang C; Li L; Xie Y; Zhang Y; Chen C; Wu Y
    Appl Microbiol Biotechnol; 2016 Jul; 100(14):6385-6393. PubMed ID: 27052378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia psittaci: new insights into genomic diversity, clinical pathology, host-pathogen interaction and anti-bacterial immunity.
    Knittler MR; Berndt A; Böcker S; Dutow P; Hänel F; Heuer D; Kägebein D; Klos A; Koch S; Liebler-Tenorio E; Ostermann C; Reinhold P; Saluz HP; Schöfl G; Sehnert P; Sachse K
    Int J Med Microbiol; 2014 Oct; 304(7):877-93. PubMed ID: 25082204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles-Adjuvanted
    Li Y; Wang C; Sun Z; Xiao J; Yan X; Chen Y; Yu J; Wu Y
    Int J Nanomedicine; 2019; 14():8179-8193. PubMed ID: 31632026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.